CRYSTALLINE FORM OF OMEPRAZOLE
A novel crystalline form of the substrate known under the chemical name 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfiny]-1H-benzimidazole, and having the generic name omeprazole, hereinafter referred to as omeprozole form C, is disclosed. Further, a process for the preparation of om...
Gespeichert in:
| Hauptverfasser: | , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; slv |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | HAFNER MILAC N EOPAR ANTON PODOBNIK BARBARA URLEB UROS KOSAK ALENKA ORNIK BRINA CIZERLE BELCIC A |
| description | A novel crystalline form of the substrate known under the chemical name 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfiny]-1H-benzimidazole, and having the generic name omeprazole, hereinafter referred to as omeprozole form C, is disclosed. Further, a process for the preparation of omeprazole form C, a pharmaceutical formulation containing omeprazole form C in admixture with pharmaceutically acceptable excipients and the use of omeprazole form C for treatment of gastrointestinal disorders are disclosed. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_SI1390360TT1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>SI1390360TT1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_SI1390360TT13</originalsourceid><addsrcrecordid>eNrjZJBzDooMDnH08fH0c1Vw8w_yVfB3U_D3dQ0Icozy93HlYWBNS8wpTuWF0twMim6uIc4euqkF-fGpxQWJyal5qSXxwZ6GxpYGxmYGISGGxsSoAQDLEiHo</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>CRYSTALLINE FORM OF OMEPRAZOLE</title><source>esp@cenet</source><creator>HAFNER MILAC N ; EOPAR ANTON ; PODOBNIK BARBARA ; URLEB UROS ; KOSAK ALENKA ; ORNIK BRINA ; CIZERLE BELCIC A</creator><creatorcontrib>HAFNER MILAC N ; EOPAR ANTON ; PODOBNIK BARBARA ; URLEB UROS ; KOSAK ALENKA ; ORNIK BRINA ; CIZERLE BELCIC A</creatorcontrib><description>A novel crystalline form of the substrate known under the chemical name 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfiny]-1H-benzimidazole, and having the generic name omeprazole, hereinafter referred to as omeprozole form C, is disclosed. Further, a process for the preparation of omeprazole form C, a pharmaceutical formulation containing omeprazole form C in admixture with pharmaceutically acceptable excipients and the use of omeprazole form C for treatment of gastrointestinal disorders are disclosed.</description><language>eng ; slv</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2007</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20070430&DB=EPODOC&CC=SI&NR=1390360T1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20070430&DB=EPODOC&CC=SI&NR=1390360T1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>HAFNER MILAC N</creatorcontrib><creatorcontrib>EOPAR ANTON</creatorcontrib><creatorcontrib>PODOBNIK BARBARA</creatorcontrib><creatorcontrib>URLEB UROS</creatorcontrib><creatorcontrib>KOSAK ALENKA</creatorcontrib><creatorcontrib>ORNIK BRINA</creatorcontrib><creatorcontrib>CIZERLE BELCIC A</creatorcontrib><title>CRYSTALLINE FORM OF OMEPRAZOLE</title><description>A novel crystalline form of the substrate known under the chemical name 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfiny]-1H-benzimidazole, and having the generic name omeprazole, hereinafter referred to as omeprozole form C, is disclosed. Further, a process for the preparation of omeprazole form C, a pharmaceutical formulation containing omeprazole form C in admixture with pharmaceutically acceptable excipients and the use of omeprazole form C for treatment of gastrointestinal disorders are disclosed.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2007</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJBzDooMDnH08fH0c1Vw8w_yVfB3U_D3dQ0Icozy93HlYWBNS8wpTuWF0twMim6uIc4euqkF-fGpxQWJyal5qSXxwZ6GxpYGxmYGISGGxsSoAQDLEiHo</recordid><startdate>20070430</startdate><enddate>20070430</enddate><creator>HAFNER MILAC N</creator><creator>EOPAR ANTON</creator><creator>PODOBNIK BARBARA</creator><creator>URLEB UROS</creator><creator>KOSAK ALENKA</creator><creator>ORNIK BRINA</creator><creator>CIZERLE BELCIC A</creator><scope>EVB</scope></search><sort><creationdate>20070430</creationdate><title>CRYSTALLINE FORM OF OMEPRAZOLE</title><author>HAFNER MILAC N ; EOPAR ANTON ; PODOBNIK BARBARA ; URLEB UROS ; KOSAK ALENKA ; ORNIK BRINA ; CIZERLE BELCIC A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_SI1390360TT13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; slv</language><creationdate>2007</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>HAFNER MILAC N</creatorcontrib><creatorcontrib>EOPAR ANTON</creatorcontrib><creatorcontrib>PODOBNIK BARBARA</creatorcontrib><creatorcontrib>URLEB UROS</creatorcontrib><creatorcontrib>KOSAK ALENKA</creatorcontrib><creatorcontrib>ORNIK BRINA</creatorcontrib><creatorcontrib>CIZERLE BELCIC A</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>HAFNER MILAC N</au><au>EOPAR ANTON</au><au>PODOBNIK BARBARA</au><au>URLEB UROS</au><au>KOSAK ALENKA</au><au>ORNIK BRINA</au><au>CIZERLE BELCIC A</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>CRYSTALLINE FORM OF OMEPRAZOLE</title><date>2007-04-30</date><risdate>2007</risdate><abstract>A novel crystalline form of the substrate known under the chemical name 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfiny]-1H-benzimidazole, and having the generic name omeprazole, hereinafter referred to as omeprozole form C, is disclosed. Further, a process for the preparation of omeprazole form C, a pharmaceutical formulation containing omeprazole form C in admixture with pharmaceutically acceptable excipients and the use of omeprazole form C for treatment of gastrointestinal disorders are disclosed.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; slv |
| recordid | cdi_epo_espacenet_SI1390360TT1 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | CRYSTALLINE FORM OF OMEPRAZOLE |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T15%3A26%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=HAFNER%20MILAC%20N&rft.date=2007-04-30&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ESI1390360TT1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |